- Home
- XENE vs ACMR Comparison
XENE vs ACMR Comparison
Compare XENE & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | ACMR |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.6B |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | XENE | ACMR |
|---|---|---|
| Price | $39.54 | $68.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $68.55 | $50.00 |
| AVG Volume (30 Days) | 589.1K | ★ 764.2K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.49 |
| Revenue | $311,000.00 | ★ $74,643,000.00 |
| Revenue This Year | N/A | $29.37 |
| Revenue Next Year | $2,496.48 | $23.16 |
| P/E Ratio | ★ N/A | $45.48 |
| Revenue Growth | N/A | ★ 104.47 |
| 52 Week Low | $35.97 | $28.46 |
| 52 Week High | $72.66 | $127.19 |
Technical Indicators
Market Signals| Indicator | XENE | ACMR |
|---|---|---|
| Relative Strength Index (RSI) | 14.04 | 40.64 |
| Support Level | N/A | $64.98 |
| Resistance Level | $45.39 | $70.56 |
| Average True Range (ATR) | 1.80 | 3.56 |
| MACD | -1.31 | -0.33 |
| Stochastic Oscillator | 2.10 | 31.70 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About ACMR ACM Research Inc.
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.